Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Scientific Reports|December 13, 2019
Possible role of highly activated mucosal NK cells against viral respiratory infections in children undergoing haematopoietic stem cell transplantationMaria Vela, Teresa Del Rosal, Antonio Pérez-Martínez, et al.
International Journal of Hematology|March 27, 2021
Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseasesMercedes Gasior Kabat, David Bueno, Luisa Sisinni, et al.
Transfusion|March 16, 2018
How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?Lucía Fernández, Alejandra Leivas, Jaime Valentín, et al.
Frontiers in Immunology|August 21, 2019
Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma ImmunotherapyMaria Vela, David Bueno, Pablo González-Navarro, et al.
Transplantation and Cellular Therapy|July 16, 2023
Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow FailureVictor Quintero, David Bueno-Sánchez, Yasmina Mozo-Del-Castillo, et al.
Frontiers in Pharmacology|November 8, 2021
Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell TransplantationIrene García-García, Irene Dapía, Jaime Montserrat, et al.
Leukemia Research|December 25, 2025
Outcomes of two distinct T-cell depletion strategies in haploidentical vs unrelated donor pediatric HSCT: A single-center retrospective analysisLuisa Sisinni, Odelaisy León-Triana, Mikel Fernandez Artazcoz, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2025
Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b studyAndreas H Groll, Lara Danziger-Isakov, Aharon Gefen, et al.
Transplantation and Cellular Therapy|March 23, 2024
Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)María Isabel Benítez Carabante, David Bueno, Laura Alonso García, et al.
The Pediatric Infectious Disease Journal|May 7, 2024
Severe Impairment of T-cell Immunity and Pulmonary GvHD Are Major Risk Factors for Nontuberculous Mycobacterial Infection After Pediatric Allogeneic Hematopoietic Stem Cell TransplantationMarina Ascunce, Alejandra Coccolo, Yasmina Mozo, et al.
Pageof 5